BridgeBio Pharma, Inc. (BBIO)
NASDAQ·Healthcare·Biotechnology
$81.82
+2.19%
Mkt Cap $15.66B
Analyst Ratings
Buy
19
Hold
1
Sell
0
Price Target (44 analysts)
$104.60
Range $83.00 – $157.00
Implied Upside
+27.8%
Consensus $104.60 vs current $81.82
NASDAQ·Healthcare·Biotechnology
$81.82
+2.19%
Mkt Cap $15.66B
Buy
19
Hold
1
Sell
0
Price Target (44 analysts)
$104.60
Range $83.00 – $157.00
+27.8%
Consensus $104.60 vs current $81.82